Table 7.

Top 50 predicted miRNAs associated with hepatocellular carcinoma based on known associations in the older version of HMDD

Rank	miRNA	Evidence	Rank	miRNA	Evidence
1	hsa-mir-155	HMDD; I; II; III; IV	26	hsa-mir-214	HMDD; I; II; III
2	hsa-mir-16-1	HMDD; I; II; III; IV	27	hsa-mir-150	HMDD; I; II; III
3	hsa-let-7a-3	HMDD; I; II; III	28	hsa-mir-181b-2	HMDD; I; II; III
4	hsa-let-7a-2	HMDD; I; II; III	29	hsa-mir-29c	HMDD; I; II
5	hsa-mir-15a	HMDD; I; II; III	30	hsa-mir-133a-1	I; III; IV
6	hsa-let-7a-1	HMDD; I; II; III	31	hsa-mir-24-1	HMDD; I; III
7	hsa-let-7b	HMDD; I; II; III	32	hsa-mir-132	I; II; III; IV
8	hsa-mir-16-2	HMDD; I; II; III; IV	33	hsa-mir-15b	HMDD; I
9	hsa-let-7d	HMDD; I; II; III	34	hsa-mir-194-1	I; II; III; IV
10	hsa-let-7c	HMDD; I; II; III	35	hsa-mir-205	HMDD; I; III; IV
11	hsa-mir-143	I; II; III	36	hsa-mir-9-3	I; III; IV
12	hsa-let-7i	HMDD; I; II	37	hsa-mir-9-2	I; II; III; IV
13	hsa-let-7f-2	HMDD; I; II; III	38	hsa-mir-25	HMDD; I; II; III
14	hsa-mir-29b-1	HMDD; I; IV	39	hsa-mir-200c	HMDD; I; II
15	hsa-mir-181b-1	HMDD; I; II; III	40	hsa-mir-373	HMDD; I
16	hsa-mir-126	HMDD; I; II; III	41	hsa-mir-429	I; IV
17	hsa-mir-133a-2	I; III; IV	42	hsa-mir-302b	HMDD; I; II; IV
18	hsa-let-7f-1	HMDD; I; II	43	hsa-mir-339	I; II
19	hsa-mir-29a	HMDD; I	44	hsa-mir-210	HMDD; I; II
20	hsa-let-7 g	HMDD; I; II; III	45	hsa-mir-30c-1	HMDD; I; II; III
21	hsa-mir-141	HMDD; I; II; III; IV	46	hsa-mir-34b	I
22	hsa-mir-106b	HMDD; I; II; III	47	hsa-mir-206	I
23	hsa-mir-146b	HMDD; I	48	hsa-mir-181a-2	HMDD; I; II; III
24	hsa-mir-9-1	I; II; III; IV	49	hsa-mir-107	HMDD; I; III
25	hsa-mir-181a-1	HMDD; I; II; III	50	hsa-mir-196a-2	HMDD; I

I, II, III and IV represent dbDEMC, PhenomiR, miR2Disease and miRwayDB, respectively